Generate a tailored SOP for Dr. Richard Lock. Improve your application with a focused, well-structured draft.
Professor Richard Lock is affiliated with the School of Clinical Medicine at UNSW Australia, specializing in childhood leukaemia. His major focus is on defining molecular mechanisms of drug resistance in relapsed childhood leukaemia. Professor Lock has developed new experimental models of childhood acute lymphoblastic leukaemia to delineate the mechanisms of programmed cell death (apoptosis) and investigate novel biological characteristics of the disease. These experimental models are also utilized to test new therapeutic agents and strategies for managing high-risk relapsed patients. He is a member of several professional societies, including the American Association for Cancer Research, American Society of Hematology, and the Australian Society for Medical Research.
Includes Business Intelligence, Enterprise Systems, and Cybersecurity Management streams.